April 18, 2017

 

https://vimeo.com/217904322/ba2736465b

Click here for a PDF version of the webcast presentation slides.

During the 1st Quarter Webcast, Portfolio Managers Dr. Ian Mortimer and Mr. Matthew Page discussed:

  • The Dividend Builder Fund (GAINX) returned 5.95% relative to the MSCI World Index of 6.53%. See full Fund and benchmark performance figures on the Q1 2017 Fact Sheet.  
  • In the first quarter, the Fund sold H&R Block and initiated a new position in Novo Nordisk. 
  • During the quarter the top 5 performers were NEX Group, Unilever, Roche Holding, Cisco Systems and Imperial Brands.  
  • The bottom 5 performers were Teva Pharmaceutical, Mattel, Novo Nordisk, Royal Dutch Shell and WPP. 

Performance as of 3/31/17

YTD 

1-Year 

3-Years 

5-Years 

10-Years 

Since Inception 

Dividend Builder Fund 

5.95% 

9.84% 

4.10% 

9.31% 

N/A 

9.30% 

MSCI World Index 

6.53% 

15.45% 

6.15% 

10.03% 

N/A 

10.02% 

Performance data quoted represents past performance; past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the Fund may be lower or higher than the performance quoted. For performance current to the most recent month end please visit, www.gafunds.com/our-funds. Total returns reflect a fee waiver in effect and in the absence of this waiver, the total returns would be lower. Index performance is not illustrative of fund performance. One cannot invest directly in an index.

The expense ratio is 2.11% (gross), 0.70% (net)*

*The Advisor has contractually agreed to reduce its fees and/or pay Fund expenses (excluding Acquired Fund Fees and Expenses, interest, taxes, dividends on short positions and extraordinary expenses) in order to limit the Fund’s Total Operating Expenses to 0.68% through June 30, 2018.

Opinions expressed are subject to change at any time, are not guaranteed and should not be considered investment advice. 

Click Here to view Fund holdings.

Click Here for the prospectus 

Fund holdings and sector allocations are subject to change and are not recommendations to buy or sell any security. 

For Registered Investment Professional Use Only